Drug & Supplement Interactions

Cissus Quadrangularis + Obinutuzumab

Brand name of Obinutuzumab

  • Gazyva

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated July 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line No Known Interaction

We found no known interaction between Cissus Quadrangularis and Obinutuzumab in our sources.

This also applies to Gazyva, a brand name of obinutuzumab.

Still Worth Knowing

  • Shared side effects: Although there is no interaction, both can cause some of the same side effects. Taken together, those side effects might add up, and a new symptom can be harder to pin on one or the other.
  • Food rule: The label for Obinutuzumab states a food rule worth keeping to.
See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking Cissus Quadrangularis with Obinutuzumab. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Cissus Quadrangularis and Obinutuzumab Interaction Check

No Known Interaction Found

We did not find a documented interaction between Obinutuzumab and Cissus Quadrangularis in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

How We Checked

Why No Interaction Is Listed for Obinutuzumab

Obinutuzumab has no interaction record with any supplement in our interaction database, so this rests on missing data, not on a study that found nothing.

Still wondering about combining Cissus Quadrangularis and Obinutuzumab? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share

Before You Combine Them

Taking Cissus Quadrangularis and Obinutuzumab Together

What to Watch For

A Side Effect Cissus Quadrangularis and Obinutuzumab Have in Common

1 side effect shows up for both Cissus Quadrangularis and Obinutuzumab.

  • Each has separately been linked to the effects below. Taken together, they might add up: the same side effect from two sources might be more likely or stronger. No study of the two together says by how much.
  • If one turns up, it can be harder to tell which one is behind it, so tell your pharmacist you take both.
  • Diarrhea Additional detail

    Cissus Quadrangularis

    Orally, Cissus quadrangularis has been reported to cause flatulence, diarrhea, gastritis, and dry mouth. However, the rates of these adverse effects are similar to or lower than that observed with placebo.

    Source: , the clinical database we license.

    4 references cited
    1. 15608. Oben J, Kuate D, Agbor G, et al. The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome. Lipids Health Dis 2006, 5:24.
    2. 16457. Oben JE, Ngondi JL, Momo CN, et al. The use of Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis 2008;7:12.
    3. 112140. Benjawan S, Nimitphong H, Tragulpiankit P, Musigavong O, Prathanturarug S, Pathomwichaiwat T. The effect of Cissus quadrangularis L. on delaying bone loss in postmenopausal women with osteopenia: A randomized placebo-controlled trial. Phytomedicine 2022;1 PubMed
    4. 43204. Panpimanmas, S., Sithipongsri, S., Sukdanon, C., and Manmee, C. Experimental comparative study of the efficacy and side effects of Cissus quadrangularis L. (Vitaceae) to Daflon (Servier) and placebo in the treatment of acute hemorrhoids. J Med Assoc.Thai

    Obinutuzumab

    Source: Obinutuzumab’s

    It lists this side effect in its Adverse Reactions section.

    Read Obinutuzumab’s label on DailyMed ›

Reported for Cissus Quadrangularis but not commonly for Obinutuzumab: bloating or gas, stomach upset, dry mouth and headache.

Note: Effects for Obinutuzumab come from the Adverse Reactions section of its FDA label; effects for Cissus Quadrangularis come from the Natural Medicines adverse-effect record, quoted above. The two sources word some effects differently, so we match them by meaning.

If You Decide to Take Both
  • Add one new thing at a time, and note the date you started it.
  • A start date turns “I’ve been feeling off” into something a pharmacist can work with.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.
Overlapping Uses

Using Cissus Quadrangularis for the Same Condition as Obinutuzumab

Why This Matters

  • The same goal. Obinutuzumab is prescribed for cancer, and Cissus Quadrangularis has been studied for it too.
  • It might help, or it might go too far. If Cissus Quadrangularis does work for it, the two effects might add up. That might mean better control, or it might go further than intended.
  • Tell your prescriber. A graded use is not a treatment, so do not stop or replace Obinutuzumab on your own. If you take Cissus Quadrangularis for the same reason, your prescriber may want to keep a closer eye on how Obinutuzumab is working.

Obinutuzumab is a prescription medicine with approved uses on its FDA label. Cissus Quadrangularis is a supplement: here is what researchers have looked at it for, and how strong that evidence is.

From the FDA Label

Obinutuzumab Is Prescribed For

Gazyva is used for certain blood cancers and one kidney condition. It is given together with other treatments in most cases.

Read the rest of what Obinutuzumab is prescribed for

It is approved for previously untreated chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and active lupus nephritis in adults who are receiving standard therapy.

From the Natural Medicines Research Record

Cissus Quadrangularis Has Been Studied For

Studied for cancer, with too little research to rate it yet.

See what the research shows
  • Cancer Studied, Not Established
    Read what the research shows

    Although there has been interest in using oral Cissus quadrangularis for cancer, there is insufficient reliable information about the clinical effects of Cissus quadrangularis for this purpose.

The grades and the research summaries are from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”.

How to Take Them

Some Obinutuzumab Products Have a Food Rule — Cissus Quadrangularis Should Not Break It

At least one FDA label for a product containing Obinutuzumab says to take it on an empty stomach. Most supplements — Cissus Quadrangularis included — are taken with a meal, so the easy mistake is swallowing both together at breakfast. Where that rule applies, keep Obinutuzumab on its own and move Cissus Quadrangularis to a meal later in the day.

This may not be true of your version. Food instructions belong to the product, not the ingredient: two Obinutuzumab products can carry different directions, and extended-release forms often differ from immediate-release ones. The label we read is quoted below — check the directions on your own box or bottle, or ask your pharmacist, for how to take the exact product you were given.

650–1,000 mg acetaminophen At least 30 minutes before GAZYVA infusion.

From the Dosage and Administration section of the FDA label we read for Obinutuzumab — where that label names a specific product, the instruction is that product's. Read the label on DailyMed ›

A food rule is not an interaction — it is about how much of the medicine you absorb. The directions that came with your own product, and your pharmacist, outrank anything on this page.

Pharmacist Q&AYou ask. We answer.

Questions Our Pharmacists Have Answered About Cissus Quadrangularis and Obinutuzumab

Real questions from readers, each answered by a licensed pharmacist at HelloPharmacist, written by a person and not generated from a database. An answer is written for the reader who asked and their situation, so read it for what to ask your own pharmacist rather than as a plan to follow.

Each one covers Cissus Quadrangularis or Obinutuzumab, not necessarily both.

  1. The pharmacist says

    Cissus quadrangularis appears to be well tolerated with little evidence of clinically significant interactions with most medications or effects on blood coagulation.

    Answered by Dr. Brian Staiger, PharmD · May 2024

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Cissus Quadrangularis Does Interact With Other Medications

Cissus Quadrangularis has 86 moderate known drug interactions in our database — Obinutuzumab isn’t one of them. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Cissus Quadrangularis

Covers the 2,830 medications we’ve checked against Cissus Quadrangularis. Pick one to open its full report.

Alternatives for the Same Use

Other Supplements Studied for Obesity, and How They Mix With Obinutuzumab

Choosing a supplement while you take Obinutuzumab? Here are other options studied for obesity, and whether each has a documented interaction with Obinutuzumab.

None of them has a documented interaction with Obinutuzumab.

11 other supplements have at least some evidence of a benefit for obesity; the 8 below come first. Cissus Quadrangularis itself is graded for it.

The grades come from the Natural Medicines database and describe the research so far, not a recommendation, and none of these supplements replaces a prescribed medicine.

One More Smart Check

Taking Cissus Quadrangularis as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Cissus Quadrangularis. We have broken down 371 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Obinutuzumab:

Get to Know Each One

About Cissus Quadrangularis and Obinutuzumab

Supplement

About Cissus Quadrangularis

Cissus Quadrangularis

Cissus quadrangularis is a traditional vine used mainly for bone health, joint pain, and weight management. Most of the supporting evidence comes from animal studies and a small number of human trials, so its benefits are not firmly proven. It appears reasonably well tolerated in the short term, but people who are pregnant, breastfeeding, or managing chronic conditions should talk to a doctor or pharmacist first.

Full Cissus Quadrangularis guide: uses, dosage, safety and every interaction
Safety at a Glance

How Cissus Quadrangularis Is Rated

  • Cissus Quadrangula... Overall

    Use caution

    Generally well tolerated in short-term use, but long-term safety is not well studied.

  • Pregnancy

    Avoid

    Not enough safety data, so it is best avoided during pregnancy.

  • Breastfeeding

    Avoid

    Not enough safety data, so it is best avoided while breastfeeding.

Medication

About Obinutuzumab Injection

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & Cissus Quadrangularis

Browse every other medication we’ve checked against Cissus Quadrangularis — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
86Moderate
0Minor
2,743No known interaction
Moderate

Moderate: 86 interactions

Showing 60 of 86 moderate interactions — see all 86 on the Cissus Quadrangularis page.

No Interaction 2,743 drugs checked — show the list
How Much People Look This Up

Where Cissus Quadrangularis and Obinutuzumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Cissus Quadrangularis
Top 25%

#338 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Obinutuzumab
Top 25%

#704 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Cissus Quadrangularis and Obinutuzumab Together: Common Questions

Can you take Cissus Quadrangularis with Obinutuzumab?
We do not list a known interaction between Cissus Quadrangularis and Obinutuzumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Can you take Cissus Quadrangularis with Gazyva?
Gazyva is a brand name of obinutuzumab, so the answer is the same as for obinutuzumab. We do not list a known interaction between Cissus Quadrangularis and Obinutuzumab. Everything on this page applies to Gazyva too.
Do Cissus Quadrangularis and Obinutuzumab have any of the same side effects?
Yes — our sources link each of them separately to one of the same effects. That is not a documented interaction, but taken together the same side effect from two sources might be more likely or stronger; no study of the two together says by how much. And if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Should I take Cissus Quadrangularis and Obinutuzumab at the same time of day?
At least one FDA label for a product containing Obinutuzumab says to take it on an empty stomach, and supplements are usually taken with a meal — so taking them together at breakfast is the easy mistake. Where that applies, keep Obinutuzumab on its own and move Cissus Quadrangularis to a meal later in the day. Food instructions belong to the product rather than the ingredient, so check the directions on your own box. This is about absorption, not an interaction.
Are Cissus Quadrangularis and Obinutuzumab used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Cissus Quadrangularis in each. That is a conversation for your prescriber, especially if Obinutuzumab is being adjusted to a target.
Do other supplements studied for obesity interact with Obinutuzumab?
None of the 11 other supplements the Natural Medicines database grades as having some evidence of a benefit for obesity has a documented interaction with Obinutuzumab. A grade is the research so far, not a recommendation, and no known interaction is not proof of safety; ask your pharmacist before adding one.
Does Cissus Quadrangularis interact with any other medications?
Yes. Cissus Quadrangularis has 86 documented drug interactions in our database — Obinutuzumab is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 4 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 4 references
  1. 15608. Oben J, Kuate D, Agbor G, et al. The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome. Lipids Health Dis 2006, 5:24.
  2. 16457. Oben JE, Ngondi JL, Momo CN, et al. The use of Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis 2008;7:12.
  3. 43204. Panpimanmas, S., Sithipongsri, S., Sukdanon, C., and Manmee, C. Experimental comparative study of the efficacy and side effects of Cissus quadrangularis L. (Vitaceae) to Daflon (Servier) and placebo in the treatment of acute hemorrhoids. J Med Assoc.Thai
  4. 112140. Benjawan S, Nimitphong H, Tragulpiankit P, Musigavong O, Prathanturarug S, Pathomwichaiwat T. The effect of Cissus quadrangularis L. on delaying bone loss in postmenopausal women with osteopenia: A randomized placebo-controlled trial. Phytomedicine 2022;1 PubMed

All 5 references behind our Cissus Quadrangularis records are listed in the Cissus Quadrangularis guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 15, 2026. The Cissus Quadrangularis and Obinutuzumab records this page draws on were last updated July 10, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About Cissus Quadrangularis and Obinutuzumab?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.